NASDAQ:NXGL NEXGEL (NXGL) Stock Price, News & Analysis → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free NXGL Stock Alerts $2.73 +0.06 (+2.25%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$2.65▼$2.7950-Day Range$1.97▼$2.9652-Week Range$1.25▼$3.14Volume4,785 shsAverage Volume37,034 shsMarket Capitalization$15.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get NEXGEL alerts: Email Address NEXGEL MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.44% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.14Based on 5 Articles This WeekInsider TradingAcquiring Shares$150,002 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.69 out of 5 starsMedical Sector869th out of 938 stocksSurgical & Medical Instruments Industry87th out of 94 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for NEXGEL. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.44% of the float of NEXGEL has been sold short.Short Interest Ratio / Days to CoverNEXGEL has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NEXGEL has recently increased by 25.97%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldNEXGEL does not currently pay a dividend.Dividend GrowthNEXGEL does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NXGL. Previous Next 2.9 News and Social Media Coverage News SentimentNEXGEL has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for NEXGEL this week, compared to 0 articles on an average week.Search Interest2 people have searched for NXGL on MarketBeat in the last 30 days. MarketBeat Follows1 people have added NEXGEL to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NEXGEL insiders have bought more of their company's stock than they have sold. Specifically, they have bought $150,002.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders27.15% of the stock of NEXGEL is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 2.21% of the stock of NEXGEL is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of NEXGEL is -5.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NEXGEL is -5.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNEXGEL has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. About NEXGEL Stock (NASDAQ:NXGL)NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Read More NXGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NXGL Stock News HeadlinesMarch 27, 2024 | globenewswire.comNEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to HolidayMarch 26, 2024 | americanbankingnews.comNEXGEL (NXGL) to Release Quarterly Earnings on ThursdayMarch 29, 2024 | Prosper Trading Academy (Ad)Did you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:March 25, 2024 | msn.comNEXGEL Sets Date for Q4 and Full-Year 2023 Earnings RevealMarch 21, 2024 | globenewswire.comNEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28thMarch 4, 2024 | globenewswire.comNEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12thFebruary 24, 2024 | msn.comNEXGEL (NXGL) Price Target Increased by 16.67% to 7.14February 23, 2024 | msn.comNEXGEL Raises Capital, Strengthens Balance Sheet Amid Growth OpportunitiesMarch 29, 2024 | Prosper Trading Academy (Ad)Did you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:February 21, 2024 | finance.yahoo.comNEXGEL Announces $975,000 Registered Direct Offering Led by InsidersJanuary 18, 2024 | finance.yahoo.comNEXGEL to Present at The Microcap Conference, January 30th through February 1stJanuary 9, 2024 | finance.yahoo.comNEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024December 11, 2023 | finance.yahoo.comNEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North AmericaDecember 7, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Neurocrine (NBIX)December 5, 2023 | finance.yahoo.comNEXGEL Acquires Kenkoderm Psoriasis Skincare LineNovember 27, 2023 | msn.comNexgel (NXGL) Price Target Increased by 20.00% to 6.12November 26, 2023 | finance.yahoo.comNEXGEL, Inc. (NASDAQ:NXGL): When Will It Breakeven?November 20, 2023 | insidermonkey.comNEXGEL, Inc. (NASDAQ:NXGL) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | msn.comNEXGEL GAAP EPS of -$0.10 beats by $0.02, revenue of $1.2M in-lineNovember 13, 2023 | finance.yahoo.comNEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-YearNovember 3, 2023 | bizjournals.comLab Notes: Montco medical technology company taps familiar face as CEONovember 2, 2023 | finance.yahoo.comNEXGEL to Report Third Quarter 2023 Financial Results on November 13thOctober 30, 2023 | proactiveinvestors.comNEXGEL announces supply agreement with AbbVieOctober 30, 2023 | finance.yahoo.comNEXGEL Secures Supply Agreement with AbbVieSeptember 26, 2023 | proactiveinvestors.comNEXGEL CEO to present at LD Micro Main Event XVI in Los AngelesSeptember 26, 2023 | finance.yahoo.comNEXGEL to Participate in the LD Micro Main Event XVI on October 3rdSeptember 15, 2023 | finance.yahoo.comDirector Scott Henry Acquires 10,500 Shares of NexGel IncSee More Headlines Receive NXGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NEXGEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2023Today3/28/2024Next Earnings (Confirmed)4/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NXGL CUSIPN/A CIK1468929 Webnexgel.com Phone215-702-8550FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,750,000.00 Net Margins-76.64% Pretax Margin-75.00% Return on Equity-38.69% Return on Assets-25.90% Debt Debt-to-Equity Ratio0.04 Current Ratio3.58 Quick Ratio2.92 Sales & Book Value Annual Sales$2.05 million Price / Sales7.62 Cash FlowN/A Price / Cash FlowN/A Book Value$1.37 per share Price / Book1.99Miscellaneous Outstanding Shares5,720,000Free Float4,166,000Market Cap$15.62 million OptionableNot Optionable Beta0.65 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Adam R. Levy (Age 61)CEO, President & Director Comp: $334.51kMr. Adam E. Drapczuk III (Age 48)Chief Financial Officer Comp: $131.04kMr. Gregory RobbVice President of OperationsKey CompetitorsSTRATA Skin SciencesNASDAQ:SSKNPAVmedNASDAQ:PAVMPetVivoNASDAQ:PETVMicrobot MedicalNASDAQ:MBOTBiotricityNASDAQ:BTCYView All CompetitorsInsidersScott Robert HenryBought 23,697 shares on 3/1/2024Total: $50,000.67 ($2.11/share)Adam E Drapczuk IIIBought 47,394 shares on 3/1/2024Total: $100,001.34 ($2.11/share)Steven Mark GlassmanBought 3,885 shares on 12/22/2023Total: $8,547.00 ($2.20/share)John Nachum SteinBought 2,500 shares on 9/26/2023Total: $4,900.00 ($1.96/share)Scott Robert HenryBought 500 shares on 9/14/2023Total: $1,135.00 ($2.27/share)View All Insider Transactions NXGL Stock Analysis - Frequently Asked Questions How have NXGL shares performed in 2024? NEXGEL's stock was trading at $2.13 at the beginning of the year. Since then, NXGL shares have increased by 28.2% and is now trading at $2.73. View the best growth stocks for 2024 here. Are investors shorting NEXGEL? NEXGEL saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 19,400 shares, an increase of 26.0% from the February 29th total of 15,400 shares. Based on an average trading volume of 21,400 shares, the short-interest ratio is presently 0.9 days. Currently, 0.4% of the shares of the stock are sold short. View NEXGEL's Short Interest. When is NEXGEL's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024. View our NXGL earnings forecast. How were NEXGEL's earnings last quarter? NEXGEL, Inc. (NASDAQ:NXGL) posted its quarterly earnings results on Monday, March, 27th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.04. The company had revenue of $0.52 million for the quarter. NEXGEL had a negative net margin of 76.64% and a negative trailing twelve-month return on equity of 38.69%. When did NEXGEL IPO? NEXGEL (NXGL) raised $14 million in an initial public offering on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at $6.83 per share. Maxim Group LLC served as the underwriter for the IPO. How do I buy shares of NEXGEL? Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NXGL) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.